从组学视角理解神经退行性疾病:经验与启示
本文综述了基因组学、转录组学和蛋白质组学在阿尔茨海默病、帕金森病、路易体痴呆和额颞叶痴呆中的研究进展,这些疾病均为65岁后发病的常见神经退行性疾病。综述旨在总结已发现的疾病相关基因、蛋白质、生物标志物及新机制,并讨论未来机遇与挑战。
要点
- 组学研究有助于揭示神经退行性疾病的多因素机制和生物标志物。
- 综述覆盖阿尔茨海默病、帕金森病、路易体痴呆和额颞叶痴呆。
- 未来需应对组学研究向临床转化中的机遇与挑战。
核心结论
- 基因组学、转录组学和蛋白质组学研究已识别神经退行性疾病的新基因、蛋白质、疾病机制和生物标志物。
研究设计与样本
- 综述性文章,聚焦65岁后发病的常见神经退行性疾病,总结基因组学、转录组学和蛋白质组学研究。
主要发现
- 神经退行性疾病由多因素过程导致分子和蛋白质网络的多效性改变,引起蛋白质失调和聚集,最终导致神经退行性变。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
As the population ages, certain neurodegenerative diseases (NDs) are becoming a major health issue. For this reason, this review will focus on the most common ND with onset after 65 years old; Alzheimer's disease, Parkinson's disease, Lewy body dementia, and frontotemporal dementia. NDs are the results of multifactorial processes causing pleiotropic changes in molecular and protein networks linking a host of biological processes that lead to protein dysregulation and aggregation that ultimately leads to neurodegeneration. Genetic, transcriptomic, and proteomic studies have been instrumental to identify novel genes and proteins implicated on diseases that point to novel disease mechanism, as well as the identification of disease biomarkers. Here, we provide a review of the genomic, transcriptomic, and proteomic studies on ND so far, as well as future opportunities and challenges. ANN NEUROL 2026;99:566-587.
引用
- Ibanez L, Pottier C, Beric A, et al. Understanding Neurodegenerative Diseases From the -Omics Perspective: Lessons Learnt. Ann Neurol. 2026. PMID: 41636082. doi:10.1002/ana.78170
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。